Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Urmi Bapat"'
Autor:
Robert Motzer, Saby George, Jaime R Merchan, Thomas E Hutson, Xun Song, Rodolfo F Perini, Ran Xie, Urmi Bapat, Javier Puente
Publikováno v:
The Oncologist.
BackgroundLenvatinib plus pembrolizumab showed significantly improved progression-free and overall survival outcomes compared with sunitinib in patients with advanced renal cell carcinoma in the CLEAR study (NCT02811861). Here, we used CLEAR data to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c9e3f831dcae11a85027550854f15e
https://doi.org/10.1093/oncolo/oyac269
https://doi.org/10.1093/oncolo/oyac269
Autor:
Thomas E. Hutson, M. Dror Michaelson, Ran Xie, Ana M. Molina, Mayer Fishman, Ulka N. Vaishampayan, Neeraj Agarwal, Urmi Bapat, Weifei Ye, Rohit Jain, James J. Hsieh, Timothy M. Kuzel
Publikováno v:
European Urology. 80:162-170
Background Non-clear cell renal cell carcinoma (nccRCC) accounts for ≤20% of RCC cases. Lenvatinib (a multitargeted tyrosine kinase inhibitor) in combination with everolimus (an mTOR inhibitor) is approved for the treatment of advanced RCC after on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd100650ff6742b1fd36fb975f765d33
https://doi.org/10.1016/j.eururo.2021.03.015
https://doi.org/10.1016/j.eururo.2021.03.015
Autor:
Urmi Bapat, Michael Dilkes
Publikováno v:
Otolaryngology–Head and Neck Surgery. 131
Objectives: Photodynamic therapy has been used to treat malignant disease since 1976. We have prospectively studieda series of 22 patients who were treated with primary photodynamic therapy for early (T1,2, N0) squamous cell carcinomas of the upper a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb64641e8e949b99282bf6a53743fb49
https://doi.org/10.1016/j.otohns.2004.06.066
https://doi.org/10.1016/j.otohns.2004.06.066
Publikováno v:
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 262(3)
The larynx is a rare site of origin of neuroendocrine carcinomas. They can be divided into typical, atypical and small cell tumours on the basis of their histopathological differentiation. The tumour histology and prognosis correlate closely. The typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6471deedfa7243bc4901c124616f636
https://pubmed.ncbi.nlm.nih.gov/15164214
https://pubmed.ncbi.nlm.nih.gov/15164214
Publikováno v:
The Journal of laryngology and otology. 115(5)
Syringing of the ear is one of the commonest procedures performed for cleaning cerumen from the external auditory canal. Common complications following syringing are pain, external auditory canal trauma and otitis externa. Hearing and vestibular loss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed836524e52d3176ac042d96ecabda39
https://pubmed.ncbi.nlm.nih.gov/11410136
https://pubmed.ncbi.nlm.nih.gov/11410136